Theragnostic Radionuclide Pairs for Prostate Cancer Management: ⁶⁴Cu/⁶⁷Cu, Can Be a Budding Hot Duo

Prostate cancer (PCa) is one of the preeminent causes of mortality in men worldwide. Theragnostic, a combination of therapy and diagnostic, using radionuclide pairs to diagnose and treat disease, has been shown to be a promising approach for combating PCa. In PCa patients, bone is one of the most co...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Anupriya Chhabra, Mathew L. Thakur
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2022-11-01
Schriftenreihe:	Biomedicines
Schlagworte:	prostate cancer theragnostic theragnostic radionuclide pairs radionuclide therapy bone metastases <sup>64</sup>Cu/<sup>67</sup>Cu
Online-Zugang:	https://www.mdpi.com/2227-9059/10/11/2787
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!